NCAM1 and non-small cell lung carcinoma: A study by Tenuta et al. demonstrated that patients with non-small cell lung cancer (NSCLC) accompanied by sarcopenia have lower levels of CD3-CD56+ NK cells and CD56dim natural killer (NK) cells (Tenuta et al., 2023).